Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CFTR | P13569 | 2/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.33 |
| ▸ | PDE9A | O76083 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL694889 | 0.93 | P2RX7 (0.40) | P2RX7MAPTRORCEPHX2HSD11B1 | |
| SCHEMBL696119 | 0.89 | HSD11B1 (0.41) | P2RX7CFTRRORCEPHX2KDM4C | |
| SCHEMBL690481 | 0.88 | TSHR (0.36) | P2RX7MAPTCFTRHSD11B1KMT2A | |
| SCHEMBL3723608 | 0.86 | RORC (0.38) | P2RX7RORCHSD11B1 | |
| SCHEMBL3718383 | 0.85 | CTSS (0.36) | P2RX7RORCHSD11B1KMT2A | |
| SCHEMBL696084 | 0.84 | P2RX7 (0.40) | P2RX7EPHX2 | |
| SCHEMBL697204 | 0.82 | KEAP1 (0.37) | RORCAGTR2 | |
| SCHEMBL694457 | 0.81 | AADAT (0.36) | MAPTHSD11B1 | |
| SCHEMBL697628 | 0.80 | CTSL (0.38) | P2RX7RORCEPHX2HSD11B1 | |
| SCHEMBL696136 | 0.80 | AADAT (0.39) | MAPTHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010121918-A1 | PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-10-28 | — | — | WO | disclosed |